We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Collagen Solutions Plc | LSE:COS | London | Ordinary Share | GB00B94T6Y14 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.625 | 6.25 | 7.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCOS
RNS Number : 8445Y
Collagen Solutions PLC
24 August 2018
Collagen Solutions Plc
(the "Company" or the "Group")
Director/PDMR Dealing
The Company today announces that on 23 August 2018 Hilary Spence, Chief Financial Officer, purchased 220,000 Ordinary Shares at a purchase price of 4.50p.
Following these purchases, Hilary Spence holds 250,817 Ordinary Shares representing approximately 0.08 per cent of the Company's issued share capital.
The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Hilary Spence 2 Reason for the notification a) Position/status Chief Financial Officer b) Initial notification / Amendment Initial 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name COLLAGEN SOLUTIONS PLC b) LEI 213800IFY1CVGRGETL95 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Ordinary shares of 1p each Identification code ISIN: GB00B94T6Y14 b) Nature of the transaction Purchase of Ordinary Shares c) Price(s) and volume(s) Price(s) Volume(s) 4.50p per share 220,000 d) Aggregated information - Aggregated volume N/A - single transaction - Price e) Date of the transaction 23 August 2018 f) Place of the transaction London Stock Exchange, XLON
Enquiries:
Collagen Solutions Plc Jamal Rushdy, CEO Via Walbrook Hilary Spence, CFO Cenkos Securities Plc (Nominated Adviser and Broker) Steve Cox (Corporate Finance) Tel: 0207 397 8900 Stephen Keys Walbrook PR Ltd Tel: 020 7933 8780 or collagen@walbrookpr.com Anna Dunphy Mob: 07876 741 001 Helen Cresswell Mob: 07841 917 679
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHFKQDQKBKDPFB
(END) Dow Jones Newswires
August 24, 2018 06:47 ET (10:47 GMT)
1 Year Collagen Solutions Chart |
1 Month Collagen Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions